Skip to main navigation
Skip to main content
Skip to Footer
Google Tag Manager
US
Sandoz Site Directory
Our Work
What We Do
Disease Areas
Quality Generics
Biosimilars
Access to Healthcare
About Us
Who We Are
Where We Do Business
Corporate Responsibility
For Novartis Investors
Contact Us
Doing Business Responsibly
Patients & Customers
Report Side Effects
Product Safety Notices
Information for Customers
Products
News
US Press Releases & News
Media Contacts
Publications
Careers
Job Search
Working at Sandoz US
Diversity & Inclusion
Search
All News
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Featured News
Media Releases
In the News
Filter By
2020
June
Media Release
/
Jun 15, 2020
Novartis manufactures and donates 27,000 units of hand sanitizer to New York State
Read More
May
Media Release
/
May 13, 2020
Sandoz Glatopa® demonstrates trend towards lower relapse rates and costs for MS patients in US compared to originator medicine in real-world study
Read More
April
Media Release
/
Apr 02, 2020
Novartis announces mutual agreement to terminate sale of Sandoz US generic oral solids, dermatology portfolio to Aurobindo
Read More
March
Media Release
/
Mar 30, 2020
Novartis donates 20,000 doses of hydroxychloroquine for COVID-19 PEP clinical trial
Read More
Media Release
/
Mar 29, 2020
Novartis donation: Consignment of 30 million hydroxychloroquine tablets ships to US Department of Health and Human Services
Read More
Media Release
/
Mar 23, 2020
Sandoz acquires US distribution rights to two key hospital injectable medicines, reinforcing strategic focus on key growth segment
Read More
Media Release
/
Mar 20, 2020
Novartis commits to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response
Read More
Media Release
/
Mar 02, 2020
Sandoz Resolves Generic Drug Antitrust Investigation in the U.S.
Read More
February
Media Release
/
Feb 06, 2020
AAM names Carol Lynch, Vice Chair of the Board
Read More
2019
November
Media Release
/
Nov 05, 2019
Sandoz receives US FDA approval for long-acting oncology supportive care biosimilar Ziextenzo™ (pegfilgrastim-bmez)
Read More
Search Results Navigation
First page
« first
Previous page
‹ previous
Page
1
of 5
Current page
2
of 5
Page
3
of 5
Page
4
of 5
Page
5
of 5
…
Next page
next ›
Last page
last »
Twitter
Tweet
Facebook
Share
Share
Twitter
Facebook
LinkedIn
Email
Jump to Comments
Print
Save
You are here
Home
›
News
›